These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 16107310)

  • 21. The effects of selective serotonin reuptake inhibitors on extracellular 5-HT levels in the hippocampus of 5-HT(1B) receptor knockout mice.
    De Groote L; Olivier B; Westenberg HG
    Eur J Pharmacol; 2002 Mar; 439(1-3):93-100. PubMed ID: 11937097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic treatment with fluvoxamine by osmotic minipumps fails to induce persistent functional changes in central 5-HT1A and 5-HT1B receptors, as measured by in vivo microdialysis in dorsal hippocampus of conscious rats.
    Bosker FJ; van Esseveldt KE; Klompmakers AA; Westenberg HG
    Psychopharmacology (Berl); 1995 Feb; 117(3):358-63. PubMed ID: 7770611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline.
    Waldinger MD; Hengeveld MW; Zwinderman AH; Olivier B
    J Clin Psychopharmacol; 1998 Aug; 18(4):274-81. PubMed ID: 9690692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new female rat animal model for hypoactive sexual desire disorder; behavioral and pharmacological evidence.
    Snoeren EM; Chan JS; de Jong TR; Waldinger MD; Olivier B; Oosting RS
    J Sex Med; 2011 Jan; 8(1):44-56. PubMed ID: 20807327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of paroxetine given repeatedly on the 5-HT receptor subpopulations in the rat brain.
    Maj J; Bijak M; Dziedzicka-Wasylewska M; Rogoz R; Rogóz Z; Skuza G; Tokarski T
    Psychopharmacology (Berl); 1996 Sep; 127(1):73-82. PubMed ID: 8880946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic paroxetine treatment does not affect sexual behavior in hormonally sub-primed female rats despite 5-HT₁(A) receptor desensitization.
    Snoeren EM; Refsgaard LK; Waldinger MD; Olivier B; Oosting RS
    J Sex Med; 2011 Apr; 8(4):976-88. PubMed ID: 21269398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulator of G-protein signaling 6 (RGS6) promotes anxiety and depression by attenuating serotonin-mediated activation of the 5-HT(1A) receptor-adenylyl cyclase axis.
    Stewart A; Maity B; Wunsch AM; Meng F; Wu Q; Wemmie JA; Fisher RA
    FASEB J; 2014 Apr; 28(4):1735-44. PubMed ID: 24421401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat.
    De Vry J; Schreiber R; Melon C; Dalmus M; Jentzsch KR
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):487-95. PubMed ID: 15589388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Destruction of serotonergic nerve terminals prevents fluoxetine-induced desensitization of hypothalamic 5-HT(1A) receptors.
    D'Souza DN; Zhang Y; Garcia F; Battaglia G; Van De Kar LD
    Psychopharmacology (Berl); 2002 Dec; 164(4):392-400. PubMed ID: 12457269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of milnacipran and fluvoxamine on hyperemotional behaviors and the loss of tryptophan hydroxylase-positive cells in olfactory bulbectomized rats.
    Saitoh A; Yamaguchi K; Tatsumi Y; Murasawa H; Nakatani A; Hirose N; Yamada M; Yamada M; Kamei J
    Psychopharmacology (Berl); 2007 May; 191(4):857-65. PubMed ID: 17318509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuronal nitric oxide synthase alteration accounts for the role of 5-HT1A receptor in modulating anxiety-related behaviors.
    Zhang J; Huang XY; Ye ML; Luo CX; Wu HY; Hu Y; Zhou QG; Wu DL; Zhu LJ; Zhu DY
    J Neurosci; 2010 Feb; 30(7):2433-41. PubMed ID: 20164327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions between corticotropin-releasing factor and the serotonin 1A receptor system on acoustic startle amplitude and prepulse inhibition of the startle response in two rat strains.
    Conti LH
    Neuropharmacology; 2012 Jan; 62(1):256-63. PubMed ID: 21835187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of acute fluoxetine, paroxetine and desipramine on rats tested on the elevated plus-maze.
    Drapier D; Bentué-Ferrer D; Laviolle B; Millet B; Allain H; Bourin M; Reymann JM
    Behav Brain Res; 2007 Jan; 176(2):202-9. PubMed ID: 17095104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the effects of the selective serotonin-reuptake inhibitors fluoxetine, paroxetine, citalopram and fluvoxamine in alcohol-preferring cAA rats.
    Maurel S; De Vry J; Schreiber R
    Alcohol; 1999 Apr; 17(3):195-201. PubMed ID: 10231167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lower anxiogenic effects of serotonin agonists are associated with lower activation of amygdala and lateral orbital cortex in adolescent male rats.
    Arrant AE; Coburn E; Jacobsen J; Kuhn CM
    Neuropharmacology; 2013 Oct; 73():359-67. PubMed ID: 23774134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delta(9)-tetrahydrocannabinol prolongs the immobility time in the mouse forced swim test: involvement of cannabinoid CB(1) receptor and serotonergic system.
    Egashira N; Matsuda T; Koushi E; Higashihara F; Mishima K; Chidori S; Hasebe N; Iwasaki K; Nishimura R; Oishi R; Fujiwara M
    Eur J Pharmacol; 2008 Jul; 589(1-3):117-21. PubMed ID: 18565508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serotonin-1A receptors in the dorsal periaqueductal gray matter mediate the panicolytic-like effect of pindolol and paroxetine combination in the elevated T-maze.
    Sela VR; Biesdorf C; Ramos DH; Zangrossi H; Graeff FG; Audi EA
    Neurosci Lett; 2011 May; 495(1):63-6. PubMed ID: 21421022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output.
    van Amsterdam C; Seyfried CA
    Psychopharmacology (Berl); 2014 Jun; 231(12):2547-58. PubMed ID: 24419272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic treatment with fluvoxamine desensitizes 5-HT2C receptor-mediated hypolocomotion in rats.
    Yamauchi M; Tatebayashi T; Nagase K; Kojima M; Imanishi T
    Pharmacol Biochem Behav; 2004 Aug; 78(4):683-9. PubMed ID: 15301922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of the serotonin reuptake blocking property of YM992: electrophysiological studies in the rat hippocampus and dorsal raphe.
    Dong J; De Montigny C; Blier P
    Synapse; 1999 Dec; 34(4):277-89. PubMed ID: 10529722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.